Legal Name: RTW INVESTMENTS LP
報告期間:
Jun 30, 2019
有効日:
Aug 14, 2019
| セキュリティ |
保有株式/元本 |
市場価格 |
オプション |
|
ROCKET PHARMACEUTICALS INC (77313F106)
|
16,587,491 |
$248,812k |
|
|
ALNYLAM PHARMACEUTICALS INC (02043Q107)
|
2,198,094 |
$159,494k |
|
|
PTC THERAPEUTICS INC (69366J200)
|
3,137,361 |
$141,181k |
|
|
DICERNA PHARMACEUTICALS INC (253031108)
|
6,152,103 |
$96,896k |
|
|
STOKE THERAPEUTICS INC COM (86150R107)
|
3,355,466 |
$92,570k |
|
|
Sarepta Therapeutics Inc (803607100)
|
604,236 |
$91,814k |
|
|
MILESTONE PHARMACEUTICALS IN (59935V107)
|
3,521,856 |
$90,967k |
|
|
ADVERUM BIOTECHNOLOGIES INC (00773U108)
|
6,320,350 |
$75,149k |
|
|
Bristol-Myers Squibb Co (110122108)
|
1,561,918 |
$70,833k |
|
|
AXONICS MODULATION TECH INC (05465P101)
|
1,534,605 |
$62,873k |
|
|
MASIMO CORP (574795100)
|
372,258 |
$55,399k |
|
|
VERICEL CORP (92346J108)
|
2,606,771 |
$49,242k |
|
|
Establishment Labs Holdings In (G31249108)
|
1,883,180 |
$41,411k |
|
|
Homology Medicines (438083107)
|
2,054,932 |
$40,215k |
|
|
ACHILLION PHARMACEUTICALS (00448Q201)
|
13,864,383 |
$37,157k |
|
|
MYOKARDIA INC (62857M105)
|
723,455 |
$36,274k |
|
|
PROQR THRAPEUTICS N V (N71542109)
|
3,722,950 |
$33,879k |
|
|
TRANSLATE BIO INC (89374L104)
|
2,439,250 |
$30,808k |
|
|
Agenus Inc (00847G705)
|
10,084,214 |
$30,253k |
|
|
Illumina Inc (452327109)
|
82,000 |
$30,188k |
|
|
ARROWHEAD PHARMACEUT (04280A100)
|
1,120,346 |
$29,689k |
|
|
MIRATI THERAPEUTICS INC (60468T105)
|
255,270 |
$26,293k |
|
|
FLUIDIGM CORP (34385P108)
|
2,077,471 |
$25,594k |
|
|
APYX MED CORP (03837C106)
|
3,399,899 |
$22,847k |
|
|
AXSOME THERAPEUTICS INC (05464T104)
|
844,289 |
$21,740k |
|
|
REGENXBIO Inc. (75901B107)
|
368,040 |
$18,906k |
|
|
LA JOLLA PHARMACEUTICAL CO (503459604)
|
2,011,340 |
$18,605k |
|
|
ARVINAS INC (04335A105)
|
807,870 |
$17,765k |
|
|
Transmedics Group Inc (89377M109)
|
507,007 |
$14,698k |
|
|
ORTHOPEDIATRICS CORP (68752L100)
|
376,647 |
$14,689k |
|
|
QUOTIENT LTD COM NPV (G73268107)
|
1,544,047 |
$14,437k |
|
|
JOHNSON & JOHNSON (478160104)
|
93,912 |
$13,080k |
|
|
ODONATE THERAPEUTICS INC (676079106)
|
339,156 |
$12,444k |
|
|
Arbutus Biopharma Corp (03879J100)
|
5,533,093 |
$11,509k |
|
|
UNIQURE N.V. (N90064101)
|
144,595 |
$11,300k |
|
|
CYTOMX THERAPEUTICS INC (23284F105)
|
988,319 |
$11,089k |
|
|
SILK ROAD MEDICAL INC COM (82710M100)
|
223,722 |
$10,842k |
|
|
Myriad Genetics Inc (62855J104)
|
376,586 |
$10,462k |
|
|
PRINCIPIA BIOPHARMA INC (74257L108)
|
270,948 |
$8,993k |
|
|
BRAINSWAY LTD (10501L106)
|
597,216 |
$6,263k |
|
|
CHARDAN HEALTHCARE ACQUISITI (15957A207)
|
600,000 |
$6,113k |
|
|
PERSONALIS INC (71535D106)
|
225,000 |
$6,109k |
|
|
CAREDX INC COM (14167L103)
|
154,616 |
$5,565k |
|
|
Argenx SE Sponsored ADR (04016X101)
|
31,448 |
$4,452k |
|
|
MOTUS GI HLDGS INC (62014P108)
|
1,126,144 |
$3,412k |
|
|
Vivus Inc 4.5 05/01/2020 (928551AA8)
|
4,000,000 |
$3,128k |
|
|
NEURONETICS (64131A105)
|
168,274 |
$2,105k |
|
|
VIVEVE MEDICAL INC (92852W204)
|
4,480,565 |
$1,703k |
|
|
VIEWRAY INC COM (92672L107)
|
159,247 |
$1,403k |
|
|
SOLID BIOSCIENCES (83422E105)
|
145,225 |
$835k |
|
|
Optinose Inc (68404V100)
|
87,615 |
$620k |
|
|
Anchiano Therapeutics, Ltd. (03280X102)
|
51,918 |
$233k |
|
